Nana-Sinkam Patrick, Kraschnewski Jennifer, Sacco Ralph, Chavez Jennifer, Fouad Mona, Gal Tamas, AuYoung Mona, Namoos Asmaa, Winn Robert, Sheppard Vanessa, Corbie-Smith Giselle, Behar-Zusman Victoria
Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
Division of General Internal Medicine, Penn State College of Medicine, Hershey, PA, USA.
J Clin Transl Sci. 2021 Mar 16;5(1):e99. doi: 10.1017/cts.2021.23.
Over the last year, COVID-19 has emerged as a highly transmissible and lethal infection. As we address this global pandemic, its disproportionate impact on Black, Indigenous, and Latinx communities has served to further magnify the health inequities in access and treatment that persist in our communities. These sobering realities should serve as the impetus for reexamination of the root causes of inequities in our health system. An increased commitment to strategic partnerships between academic and nonacademic health systems, industry, local communities, and policy-makers may serve as the foundation. Here, we examine the impact of the recent COVID-19 pandemic on health care inequities and propose a strategic roadmap for integration of clinical and translational research into our understanding of health inequities.
在过去一年里，新冠病毒已成为一种具有高度传染性和致命性的感染源。在应对这一全球大流行时，它对黑人、原住民和拉丁裔社区造成的不成比例影响，进一步凸显了我们社区在医疗服务可及性和治疗方面长期存在的健康不平等问题。这些严峻现实应成为重新审视我们医疗体系中不平等现象根源的动力。加大对学术与非学术医疗体系、行业、当地社区及政策制定者之间战略伙伴关系的投入，或许可作为基础。在此，我们审视近期新冠疫情对医疗不平等的影响，并提出将临床和转化研究融入我们对健康不平等理解的战略路线图。
